相关实验视频

Updated: Jul 19, 2025

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

作为胃癌患者潜在的治疗标:目前的洞察力

Annesha Chatterjee¹, Jordana Maria Azevedo-Martins¹, Matthew D Stachler¹

¹University of California San Francisco, Department of Pathology, San Francisco, CA, USA.

OncoTargets and therapy

|August 16, 2023

概括

干白素33 (IL-33) 在胃癌 (GC) 的发展和进展中起着复杂的作用. 针对IL-33信号传递可能为这种流行疾病提供新的治疗策略.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

胃癌 (GC) 是全球癌症死亡的主要原因.
目前用于晚期GC的治疗方法的疗效有限.
了解分子信号通路对于新的治疗点至关重要.

研究的目的:

为了审查Interleukin 33 (IL-33) 在胃癌中的多方面的作用.
阐明IL-33在GC发育和进展中的功能.
为了确定潜在的治疗策略,针对GC中的IL-33.

主要方法:

文献综述总结了关于胃癌IL-33的当前研究.
分析IL-33的双细胞因子和核因子活动.
检查IL-33与其受体ST2L的相互作用以及下游信号传输.

主要成果:

IL-33信号传递可以通过免疫细胞招募和转化形成促进胃癌.
在GC细胞中,IL-33可能会诱导干细胞类和上皮细胞-介质细胞过渡 (EMT) 特性.
在GC中IL-33的确切作用仍在调查中,有一些相互矛盾的发现.

结论:

在胃癌中,IL-33表现出支持瘤的功能.
干扰IL-33信号传递为GC预防和治疗提供了潜在的治疗途径.
需要进一步的研究,以充分理解和利用IL-33在GC中的作用.

关键词:

胃癌胃癌是一种胃癌.介质蛋白-33 介质蛋白-33 治疗目标是治疗的目标.

更多相关视频

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...